PM hosts life sciences roundtable in New York
Twelve of the top US life science companies met with PM David Cameron at Rockefeller University in New York.
The PM hears from leaders from the life sciences industry.
Prime Minister David Cameron met with life sciences industry leaders to emphasise the UK’s ongoing and long-term commitment to life sciences and to acknowledge the value and investment that the US companies bring to the UK. The PM highlighted genomic medicine and dementia research as priority areas he would like the companies to consider for future investment.
The PM addresses guests at the life sciences roundtable at Rockefeller University.
The 12 companies represented – Abbvie, Amgen, Baxter, Biogen Idec, Bristol-Myers Squibb, Covance, Eli Lilly, Gilead, Johnson & Johnson, Merck, Pfizer, and Thermo Fisher Scientific – identified areas where they thought the UK could improve to encourage future investment. These were: the need for quicker access to patients, unlocking innovation collaborations with British universities, and ensuring pricing benefits both patients and companies. The PM welcomed their constructive feedback.
The PM learns about the neurodegenerative research with scientists at Rockefeller University. From left to right: Dr Cynthia Duggan, Dr Dominik Paquet, the PM, Dr Olav Olsen, and Dr Marc Tessier-Lavigne.
Marc Tessier-Lavigne, PhD, the President of Rockefeller University, invited the PM behind the scenes to his lab to learn about research being carried out that is helping advance world knowledge on neurodegenerative disorders, including dementia.
Consul General Danny Lopez bids farewell to the PM and thanks Dr Tessier-Lavigne for the tour of Rockefeller University's laboratory.